OHIM Grants EU Trademark for babyLance Infant Heel Incision Device
The Medical Device's Trademark is Also Registered in the United States, Australia, China, South Korea, Singapore and Switzerland
Alicante, Spain, November 22, 2011 --(PR.com)-- MediPurpose(r), a master distributor and manufacturer of medical products, announced today that the babyLance(r) infant heel incision device trademark is now protected in the European Union.
The Statement of Grant of Protection issued by the Office for Harmonization in the Internal Market (OHIM) protects both the word "babyLance" and the neonatal heel stick's unique blue and green logo.
The medical device's trademark is also registered in the United States, Australia, China, South Korea, Singapore and Switzerland.
The babyLance name and logo was designed by MediPurpose with the cooperation of an international graphics consultant who also designed the logo for the SurgiLance(r) safety lancet and MediPlus(tm) Advanced Wound Care products.
babyLance is a single-use heel incision device utilized to obtain a blood sample from the heels of newborn (babyLance BLN) and preemie (babyLance BLP) infants.
More information about babyLance -- including no-cost product sample requests -- is available at http://www.medipurpose.com/babylance/ .
About OHIM
The Office for Harmonization in the Internal Market (OHIM) is the official trademarks and designs office of the European Union.
OHIM registers the Community trademark (CTM) and registered Community design (RCD), which are essential components of the European single market. These registrations provide trademark and design protection throughout the European Union, which covers 27 countries and approximately 500 million people.
OHIM also works in close partnership with national IP offices in the EU member states, with international offices, and the European Commission on a wide range of issues affecting the owners and users of intellectual property rights.
For more information about OHIM, please visit http://oami.europa.eu/ .
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance(r) heel incision device, SurgiLance(r) safety lancet and MediPlus(tm) advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com .
###
The Statement of Grant of Protection issued by the Office for Harmonization in the Internal Market (OHIM) protects both the word "babyLance" and the neonatal heel stick's unique blue and green logo.
The medical device's trademark is also registered in the United States, Australia, China, South Korea, Singapore and Switzerland.
The babyLance name and logo was designed by MediPurpose with the cooperation of an international graphics consultant who also designed the logo for the SurgiLance(r) safety lancet and MediPlus(tm) Advanced Wound Care products.
babyLance is a single-use heel incision device utilized to obtain a blood sample from the heels of newborn (babyLance BLN) and preemie (babyLance BLP) infants.
More information about babyLance -- including no-cost product sample requests -- is available at http://www.medipurpose.com/babylance/ .
About OHIM
The Office for Harmonization in the Internal Market (OHIM) is the official trademarks and designs office of the European Union.
OHIM registers the Community trademark (CTM) and registered Community design (RCD), which are essential components of the European single market. These registrations provide trademark and design protection throughout the European Union, which covers 27 countries and approximately 500 million people.
OHIM also works in close partnership with national IP offices in the EU member states, with international offices, and the European Commission on a wide range of issues affecting the owners and users of intellectual property rights.
For more information about OHIM, please visit http://oami.europa.eu/ .
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance(r) heel incision device, SurgiLance(r) safety lancet and MediPlus(tm) advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and distributors.
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose's medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com .
###
Contact
MediPurpose
Derek Rudnak
888-808-6494
www.medipurpose.com
Derek Rudnak
888-808-6494
www.medipurpose.com
Contact
Categories